Hangzhou Jiuyuan Gene Engineering Co Ltd Class H ( (HK:2566) ) has shared an update.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. announced an update regarding its final cash dividend for the year ended December 31, 2024. The dividend is set at RMB 0.56 per 10 shares, with the ex-dividend date on June 13, 2025, and payment scheduled for July 30, 2025. The announcement also includes details on withholding tax rates applicable to non-resident shareholders, which vary based on tax treaties between their country of domicile and the PRC. This update reflects the company’s commitment to shareholder returns and provides clarity on tax implications for international investors.
More about Hangzhou Jiuyuan Gene Engineering Co Ltd Class H
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H is a company operating in the genetic biopharmaceutical industry, focusing on the development and distribution of genetic and biopharmaceutical products.
YTD Price Performance: -10.30%
Average Trading Volume: 238,294
For a thorough assessment of 2566 stock, go to TipRanks’ Stock Analysis page.